Perfil de la empresa · Healthcare

Hangzhou Tigermed Consulting

300347 · Shenzhen
Bolsa
Shenzhen
País / Región
China
Fecha de salida a bolsa
17 de agosto de 2012
Empleados
11.130
Precio actual
¥51.9
En vivo · 15 de julio de 2026
Compra razonable
≤ ¥27
Entrada con margen de seguridad
Puntuación de crecimiento Baillie
44/100
Floja
Valor intrínseco · Rango en tres niveles Precio actual ¥51.9 En vivo · Dentro del rango de valor intrínseco razonable

Rango de valoración compuesto · conservador ¥24–¥27 / razonable ¥43–¥58 / optimista ¥79–¥86. A ¥51.9, Dentro del rango de valor intrínseco razonable.

Capitalización39,86 mil M CNY
Ingresos (TTM)7070,13 M CNY
EBITDA824,11 M CNY
Margen neto10,91 %
ROE4,23 %
PER (TTM)50,87
PER previsto28,99
PEG0
BPA0,91 CNY
Rentabilidad por dividendo0,27 %
Rango de 52 semanas35,47 CNY – 71,69 CNY

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Hangzhou Tigermed Consulting Co., Ltd, together with its subsidiaries, provides contract research organization services in the People's Republic of China and internationally. The company offers clinical trial operation services, such as clinical pharmacology, registration and regulatory affairs, scientific affairs, medical translation, pharmacovigilance, real-world research, third-party auditing and training, etc. for innovative drugs, generic drugs, and medical devices, as well as supporting services directly related to clinical trials, including clinical operation, clinical trials, and clinical trials management. It also provides clinical trial related and laboratory services in the drug development process comprising data management and statistical analysis, clinical trial site management, subject recruitment, medical imaging, and laboratory services. In addition, the company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, decentralized clinical trials, clinical development strategy, site management, medical device/in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. Further, it provides medical imaging, pharmacovigilance, medical translation, quality assurance, GMP and medical device consulting, central laboratories, functional services, recruitment management, EDC cloud-based system, and remote follow-up center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and SAS project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.

Aún no hay análisis sobre este valor en tu idioma.